John Lacy III

Insider Reports History

Entity
Individual
Location
10025 Investment Drive, Suite 250, Knoxville, TN
Signature
/s/ John Lacey III
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Lacy III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Director Series D-1 Convertible Preferred Stock 180K Sep 30, 2024 Direct

Insider Reports Filed by John Lacy III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PVCT PROVECTUS BIOPHARMACEUTICALS, INC. Sep 30, 2024 1 $0 4 Sep 30, 2024 Director